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Bringing order to early B cell chaos
In the early 1990s, Richard (Randy) Hardy and colleagues divided B cell 
precursors into subpopulations—the Hardy fractions—based on the cells’ 
expression of various cell surface proteins. This classification helped lay 
the groundwork for our present-day understanding of the molecular events 
that control early B cell development.
B cell precursors progress through an 
ordered series of developmental steps in 
the bone marrow before reaching 
maturity. The details of this process are 
now well defined, but a mere two 
decades ago the picture was far less clear, 
in part because it was difficult to follow 
single cells from birth to maturity.
Tracking these cells would require 
detailed fractionation of the cells using 
monoclonal antibodies (mAbs) specific 
for a panoply of cell surface markers. 
There are those who curse the alphabet 
soup of immune cell surface markers. 
But those long lists—which started 
with the ingenuity of Hardy—allow us 
to make sense out of otherwise identical 
looking collections of cells.
FACS revolution
In the 1970s, Max Cooper, Dennis 
Osmond, and others discovered that 
immunoglobulin (Ig)-bearing B cells 
arose from Ig-negative precursor cells 
in the bone marrow. These precursor 
cells—dubbed pre-B cells by Cooper—
had synthesized part of the receptor 
(Ig heavy chains), which could be de-
tected in the cytoplasm, but had yet to 
assemble a complete receptor on the 
cell surface (1).
Osmond later pinpointed a more 
primitive population of cells (pro-B 
cells) that had not yet synthesized μ 
heavy chains (2). But the cellular pheno-
types that might be lurking between the 
pro-B and pre-B cell stages remained 
mysterious, as there was no way to pick 
apart this mixed bag of cells.
Also problematic was the inability 
to grow B cell precursors in culture. As 
a result, many of the early insights into 
B cell development—including the or-
dered rearrangement of the V, D, and J 
gene segments of the Ig locus—came 
from studies using transformed B cell 
lines. The discovery that stromal cells 
could support the growth and differen-
tiation of primary B cell precursors 
soon overcame this obstacle (3, 4).
Then came multicolor (multilaser) 
flow cytometry, a technique that revo-
lutionized the study of B cell develop-
ment (and immunology as a whole) by 
allowing single cells to be stained 
simultaneously with multiple fluores-
cently tagged mAbs. Hardy—a chemist 
by training—used one of the first multi-
laser FACS (fluorescence activated cell 
sorter) machines to investigate mature 
B cell subpopulations as a post-doc 
with Leonore and Leonard Herzenberg 
in the early 1970s (5, 6).
Partitioning pre- and pro-B
With these techniques in hand, plus a 
battery of lymphocyte-specific mAbs 
(generated by the Herzenbergs, John 
Kemp, and others), Hardy—by then a 
new faculty member at Fox Chase 
Cancer Center (Philadelphia)—set out 
to explore the diversity of B cell pre-
cursors. He started by dividing B220+ 
bone marrow cells based on their ex-
pression of CD43, BP-1 and CD24.
Sorting the CD43+ populations of 
cells and culturing them in vitro re-
vealed their order of differentiation: 
fraction A (BP-1–/CD24–) begot frac-
tion B (BP-1–/CD24+), which in turn 
begot fraction C (BP-1+/CD24+). 
Later (CD43–) populations could be 
distinguished by their expression of 
surface IgM and IgD. “It was so strik-
ing the way you could sort these cells 
and see the progression,” says Hardy.
Hardy confirmed the developmental 
order of the cells by amplifying the Ig 
genes from each fraction. The Ig genes 
from fraction A cells were in a germline 
configuration, whereas those from frac-
tions B and C had D-J, but not V-D-J 
rearrangements, consistent with previ-
ous studies. Hardy published these data, 
along with his fractionation scheme, in 
1991 in The Journal of Experimental 
Medicine (7).
Markers multiply
Hardy was not alone in his attempt to 
bring order to early B cell develop-
ment. Fritz Melchers and colleagues in 
Basel, Switzerland, who discovered the 
surrogate light chain, added c-kit and 
CD25 to the growing list of B cell 
markers (8). That list now goes on and 
on (and FACS is up to 17 colors), with 
each new marker revealing new layers 
of diversity. As Melchers puts it, “It’s a 
mess, but it’s a beautiful mess.” Hardy 
prefers to call it a “beautiful complex-
ity,” adding, “It’s like a fractal—the 
deeper you look, the more you see.”
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FACS plot of Hardy fractions A-C. Adapted 
from reference 7.